Danielle Bitterman/LinkedIn
May 17, 2025, 15:22
Danielle Bitterman: Generating Evidence, Engaging Patients, and Investing in Trust Will Get us Where we Need to Go
Danielle Bitterman, Assistant Professor at Harvard Medical School, shared a post on LinkedIn:
“What a great discussion today on how artificial intelligence is reshaping cancer care at STAT’s 2025 Breakthrough West Summit alongside Clifford Hudis, CEO of ASCO, Karen Knudsen, CEO of Parker Institute for Cancer Immunotherapy, and Angus Chen, STAT’s leading cancer reporter.
AI holds incredible promise in shaping the future of oncology — from earlier and more precise diagnoses to personalized treatment planning that greatly improves outcomes for patients.
Key takeaway – Generating evidence, engaging patients, and investing in trust and transparency will get us where we need to go.
Thank you to STAT and my co-panelists for fostering a thoughtful dialogue on how the advancements we are witnessing today set the stage for a future where AI tools redefine cancer treatment as we know it.”
More posts featuring Danielle Bitterman.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 17, 2025, 15:15
May 17, 2025, 15:04
May 17, 2025, 15:03
May 17, 2025, 14:56
May 17, 2025, 12:46